US 9063153
Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
granted A61KA61K31/785A61K38/02
Quick answer
US patent 9063153 (Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/785, A61K38/02, A61K38/07, A61K9/0019